Cyclosporin A suppresses the expression of the interleukin 2 gene by inhibiting the binding of lymphocyte-specific factors to the IL-2 enhancer - PubMed (original) (raw)
Comparative Study
Cyclosporin A suppresses the expression of the interleukin 2 gene by inhibiting the binding of lymphocyte-specific factors to the IL-2 enhancer
C Randak et al. EMBO J. 1990 Aug.
Abstract
Cyclosporin A (CsA), a powerful immunosuppressive drug, inhibits the synthesis of lymphokines in T lymphocytes at the level of gene transcription. Using protein extracts from El4 lymphoma cells we show that the binding of lymphocyte-specific factors interacting with the two so-called purine boxes (Pu-boxes) of the interleukin 2 (IL-2) enhancer are missing in CsA-treated cells. The CsA-sensitive factors are newly synthesized upon induction. The most prominent factor consists of 45 kd polypeptides and contacts both Pu-boxes at the two central G residues within the identical core sequence AAGAGGAAAA. The CsA-mediated suppression of factor binding to the Pu-boxes correlates well with functional studies in which the inducible, T cell-restricted proto-enhancer activity of Pu-boxes was selectively repressed by CsA. These observations support the conclusion that the suppression of factor binding to the Pu-boxes by CsA impairs the activity of IL-2 and of further lymphokine genes, thereby inhibiting the synthesis of lymphokines in T lymphocytes.
Similar articles
- The immunosuppressives FK 506 and cyclosporin A inhibit the generation of protein factors binding to the two purine boxes of the interleukin 2 enhancer.
Brabletz T, Pietrowski I, Serfling E. Brabletz T, et al. Nucleic Acids Res. 1991 Jan 11;19(1):61-7. doi: 10.1093/nar/19.1.61. Nucleic Acids Res. 1991. PMID: 1707162 Free PMC article. - The immunosuppressant FK-506 specifically inhibits mitogen-induced activation of the interleukin-2 promoter and the isolated enhancer elements NFIL-2A and NF-AT1.
Banerji SS, Parsons JN, Tocci MJ. Banerji SS, et al. Mol Cell Biol. 1991 Aug;11(8):4074-87. doi: 10.1128/mcb.11.8.4074-4087.1991. Mol Cell Biol. 1991. PMID: 1712901 Free PMC article. - Stimulation of lymphokine release from T lymphoblasts. Requirement for mRNA synthesis and inhibition by cyclosporin A.
Granelli-Piperno A, Inaba K, Steinman RM. Granelli-Piperno A, et al. J Exp Med. 1984 Dec 1;160(6):1792-802. doi: 10.1084/jem.160.6.1792. J Exp Med. 1984. PMID: 6334715 Free PMC article. - Inducible nuclear factor binding to the kappa B elements of the human immunodeficiency virus enhancer in T cells can be blocked by cyclosporin A in a signal-dependent manner.
Schmidt A, Hennighausen L, Siebenlist U. Schmidt A, et al. J Virol. 1990 Aug;64(8):4037-41. doi: 10.1128/JVI.64.8.4037-4041.1990. J Virol. 1990. PMID: 2196387 Free PMC article. - Molecular mechanisms of immunosuppression by cyclosporins.
Zenke G, Baumann G, Wenger R, Hiestand P, Quesniaux V, Andersen E, Schreier MH. Zenke G, et al. Ann N Y Acad Sci. 1993 Jun 23;685:330-5. doi: 10.1111/j.1749-6632.1993.tb35882.x. Ann N Y Acad Sci. 1993. PMID: 7689806 Review.
Cited by
- One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.
Briegel K, Hentsch B, Pfeuffer I, Serfling E. Briegel K, et al. Nucleic Acids Res. 1991 Nov 11;19(21):5929-36. doi: 10.1093/nar/19.21.5929. Nucleic Acids Res. 1991. PMID: 1945879 Free PMC article. - cis-acting sequences required for inducible interleukin-2 enhancer function bind a novel Ets-related protein, Elf-1.
Thompson CB, Wang CY, Ho IC, Bohjanen PR, Petryniak B, June CH, Miesfeldt S, Zhang L, Nabel GJ, Karpinski B, et al. Thompson CB, et al. Mol Cell Biol. 1992 Mar;12(3):1043-53. doi: 10.1128/mcb.12.3.1043-1053.1992. Mol Cell Biol. 1992. PMID: 1545787 Free PMC article. - Two cytotoxic cell proteinase genes are differentially sensitive to sodium butyrate.
Frégeau CJ, Helgason CD, Bleackley RC. Frégeau CJ, et al. Nucleic Acids Res. 1992 Jun 25;20(12):3113-9. doi: 10.1093/nar/20.12.3113. Nucleic Acids Res. 1992. PMID: 1620608 Free PMC article. - The NFAT-1 DNA binding complex in activated T cells contains Fra-1 and JunB.
Boise LH, Petryniak B, Mao X, June CH, Wang CY, Lindsten T, Bravo R, Kovary K, Leiden JM, Thompson CB. Boise LH, et al. Mol Cell Biol. 1993 Mar;13(3):1911-9. doi: 10.1128/mcb.13.3.1911-1919.1993. Mol Cell Biol. 1993. PMID: 8441422 Free PMC article.
References
- Nature. 1989 Feb 2;337(6206):476-8 - PubMed
- Mol Cell Biol. 1982 Sep;2(9):1044-51 - PubMed
- Science. 1989 Apr 28;244(4903):457-60 - PubMed
- EMBO J. 1989 Feb;8(2):465-73 - PubMed
- Mol Cell Biol. 1989 Mar;9(3):1041-8 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources